Almunda Professionals (AMUND) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
13 Oct, 2025Executive summary
Delivered solid performance in a challenging market, with revenue of €13.1 million, down from €14.6 million year-over-year.
EBITDA decreased to €1.7 million from €2.7 million in the same period last year.
Net result attributable to shareholders was €0.7 million negative, mainly due to higher non-cash amortization charges.
Adjusted net result (excluding amortization) was €0.5 million positive.
No expectation to recover first-half shortfall in the second half; full-year revenue and EBITDA expected to be lower.
Financial highlights
Revenue: €13.1 million (2024: €14.6 million), EBITDA: €1.7 million (2024: €2.7 million), EBIT: -€0.2 million (2024: €1.0 million).
Net result attributable to shareholders: -€0.7 million (2024: €0.2 million).
Net cash position: €3.1 million (2024: €3.3 million).
Solvency ratio: 40% (2024: 37%).
Net result per share: -€0.03 (2024: €0.01); adjusted for amortization: €0.02 (2024: €0.06).
Outlook and guidance
Full-year 2025 revenue and EBITDA expected to be lower than 2024 due to inability to recover first-half shortfall.
Novisource expected to recover over the next 12 months; ICE continues to see strong demand.
Anticipated add-on acquisition in the utilities sector to strengthen ICE's position.
Latest events from Almunda Professionals
- Revenue up 57% to €20.5M, but net loss of €1.7M driven by healthcare segment challenges.AMUND
H1 2026 - Revenue up 8% to €31.4m; stable EBITDA; net loss €0.58m; positive 2026 outlook.AMUND
H2 2025 - Revenue up 20% to €14.6m, but profit outlook cautious amid tougher market.AMUND
H1 2024 - Revenue up, net result down; PIDZ pivots, ICE grows, Novisource restructures.AMUND
H2 2024